Cargando…
Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332521/ https://www.ncbi.nlm.nih.gov/pubmed/30642386 http://dx.doi.org/10.1186/s13063-018-3155-9 |
| _version_ | 1783387369632694272 |
|---|---|
| author | Lawrence, David S. Youssouf, Nabila Molloy, Síle F. Alanio, Alexandre Alufandika, Melanie Boulware, David R. Boyer-Chammard, Timothée Chen, Tao Dromer, Francoise Hlupeni, Admire Hope, William Hosseinipour, Mina C. Kanyama, Cecilia Lortholary, Oliver Loyse, Angela Meya, David B. Mosepele, Mosepele Muzoora, Conrad Mwandumba, Henry C. Ndhlovu, Chiratidzo E. Niessen, Louis Schutz, Charlotte Stott, Katharine E. Wang, Duolao Lalloo, David G. Meintjes, Graeme Jaffar, Shabbar Harrison, Thomas S. Jarvis, Joseph N. |
| author_facet | Lawrence, David S. Youssouf, Nabila Molloy, Síle F. Alanio, Alexandre Alufandika, Melanie Boulware, David R. Boyer-Chammard, Timothée Chen, Tao Dromer, Francoise Hlupeni, Admire Hope, William Hosseinipour, Mina C. Kanyama, Cecilia Lortholary, Oliver Loyse, Angela Meya, David B. Mosepele, Mosepele Muzoora, Conrad Mwandumba, Henry C. Ndhlovu, Chiratidzo E. Niessen, Louis Schutz, Charlotte Stott, Katharine E. Wang, Duolao Lalloo, David G. Meintjes, Graeme Jaffar, Shabbar Harrison, Thomas S. Jarvis, Joseph N. |
| author_sort | Lawrence, David S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6332521 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63325212019-01-16 Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial Lawrence, David S. Youssouf, Nabila Molloy, Síle F. Alanio, Alexandre Alufandika, Melanie Boulware, David R. Boyer-Chammard, Timothée Chen, Tao Dromer, Francoise Hlupeni, Admire Hope, William Hosseinipour, Mina C. Kanyama, Cecilia Lortholary, Oliver Loyse, Angela Meya, David B. Mosepele, Mosepele Muzoora, Conrad Mwandumba, Henry C. Ndhlovu, Chiratidzo E. Niessen, Louis Schutz, Charlotte Stott, Katharine E. Wang, Duolao Lalloo, David G. Meintjes, Graeme Jaffar, Shabbar Harrison, Thomas S. Jarvis, Joseph N. Trials Correction BioMed Central 2019-01-14 /pmc/articles/PMC6332521/ /pubmed/30642386 http://dx.doi.org/10.1186/s13063-018-3155-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Lawrence, David S. Youssouf, Nabila Molloy, Síle F. Alanio, Alexandre Alufandika, Melanie Boulware, David R. Boyer-Chammard, Timothée Chen, Tao Dromer, Francoise Hlupeni, Admire Hope, William Hosseinipour, Mina C. Kanyama, Cecilia Lortholary, Oliver Loyse, Angela Meya, David B. Mosepele, Mosepele Muzoora, Conrad Mwandumba, Henry C. Ndhlovu, Chiratidzo E. Niessen, Louis Schutz, Charlotte Stott, Katharine E. Wang, Duolao Lalloo, David G. Meintjes, Graeme Jaffar, Shabbar Harrison, Thomas S. Jarvis, Joseph N. Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial |
| title | Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial |
| title_full | Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial |
| title_fullStr | Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial |
| title_full_unstemmed | Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial |
| title_short | Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial |
| title_sort | correction to: ambisome therapy induction optimisation (ambition): high dose ambisome for cryptococcal meningitis induction therapy in sub-saharan africa: study protocol for a phase 3 randomised controlled non-inferiority trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332521/ https://www.ncbi.nlm.nih.gov/pubmed/30642386 http://dx.doi.org/10.1186/s13063-018-3155-9 |
| work_keys_str_mv | AT lawrencedavids correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT youssoufnabila correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT molloysilef correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT alanioalexandre correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT alufandikamelanie correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT boulwaredavidr correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT boyerchammardtimothee correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT chentao correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT dromerfrancoise correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT hlupeniadmire correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT hopewilliam correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT hosseinipourminac correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT kanyamacecilia correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT lortholaryoliver correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT loyseangela correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT meyadavidb correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT mosepelemosepele correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT muzooraconrad correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT mwandumbahenryc correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT ndhlovuchiratidzoe correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT niessenlouis correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT schutzcharlotte correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT stottkatharinee correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT wangduolao correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT lalloodavidg correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT meintjesgraeme correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT jaffarshabbar correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT harrisonthomass correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial AT jarvisjosephn correctiontoambisometherapyinductionoptimisationambitionhighdoseambisomeforcryptococcalmeningitisinductiontherapyinsubsaharanafricastudyprotocolforaphase3randomisedcontrollednoninferioritytrial |